1. Yao, Kevin, Zhou, Emily, Schaafsma, Evelien, Zhang, Baoyi, Cheng, Chao. 2022. Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes. In Cancer medicine, 12, 5590-5602. doi:10.1002/cam4.5409. https://pubmed.ncbi.nlm.nih.gov/36394080/
2. Qie, Chenxin, Jiang, Jingwei, Liu, Wanmei, Xie, Xiaoxue, Liu, Jun. 2020. Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of skin macrophages in Vsir-/- murine psoriasis. In Theranostics, 10, 10483-10497. doi:10.7150/thno.45614. https://pubmed.ncbi.nlm.nih.gov/32929361/
3. Guldner, Ian H, Wang, Qingfei, Yang, Lin, Landreth, Gary E, Zhang, Siyuan. 2020. CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10. In Cell, 183, 1234-1248.e25. doi:10.1016/j.cell.2020.09.064. https://pubmed.ncbi.nlm.nih.gov/33113353/
4. Mo, Jianshan, Deng, Lin, Peng, Keren, Wang, Yuanxiang, Zhang, Xiaolei. 2023. Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia. In Journal of hematology & oncology, 16, 15. doi:10.1186/s13045-023-01410-y. https://pubmed.ncbi.nlm.nih.gov/36849939/
5. Zhang, Jian, Peng, Yuhui, He, Yan, Guo, Penxiang, Zhang, Qifang. 2021. GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression. In Biochimica et biophysica acta. Molecular basis of disease, 1868, 166268. doi:10.1016/j.bbadis.2021.166268. https://pubmed.ncbi.nlm.nih.gov/34536536/
6. Pan, Jun, Mahsud, Ihsanullah, Ul Haq, Moeen, Ullah, Sajid, Jamil, Muhammad. 2024. Comprehensive pan-cancer analysis reveals VSIR as a candidate immunologic, diagnostic, and prognostic biomarker. In American journal of translational research, 16, 1630-1642. doi:10.62347/JMBZ8836. https://pubmed.ncbi.nlm.nih.gov/38883368/
7. McMiller, Tracee L, Besharati, Sepideh, Yarchoan, Mark, Anders, Robert A, Topalian, Suzanne L. 2024. Immune microenvironment of Epstein-Barr virus (EBV)-negative compared to EBV-associated gastric cancers: implications for immunotherapy. In Journal for immunotherapy of cancer, 12, . doi:10.1136/jitc-2024-010201. https://pubmed.ncbi.nlm.nih.gov/39572160/
8. Zeng, Hanqian, Shen, Yanyan, Hirachan, Suzita, Bhandari, Adheesh, Zhang, Xiangjian. 2021. Pan-cancer investigation of CENPK gene: clinical significance and oncogenic immunology. In American journal of translational research, 13, 13336-13355. doi:. https://pubmed.ncbi.nlm.nih.gov/35035680/
9. Hoffman, Samantha E, Dowrey, Todd W, Villacorta Martin, Carlos, Van Allen, Eliezer M, Murphy, George J. 2023. Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors. In Science advances, 9, eadd9668. doi:10.1126/sciadv.add9668. https://pubmed.ncbi.nlm.nih.gov/37756410/
10. Ren, Ran, Chang, Xin, Chen, Cong, Yu, Hao, Han, Lu. 2023. VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature. In Open medicine (Warsaw, Poland), 18, 20230866. doi:10.1515/med-2023-0866. https://pubmed.ncbi.nlm.nih.gov/38152334/